About this trial
People who undergo allogeneic bone marrow transplant for blood cancers receive the highest chemotherapy doses possible that humans can receive and still survive. As a result, they have devastating side effects during the procedure and for many years afterwards. Damage to organs and muscles cause long-lasting physical weakness and the psychological experience is severe enough to be termed 'post traumatic stress disorder' that also lasts for many years. These effects are worsened by the fact that most Canadians live several hours away from treatment and transplant centers, leaving them entirely on their own to manage these difficult long term effects. The APOLLO team will perform a qualitative study to learn the experiences of people undergoing allogeneic bone marrow transplant while they receive access to a supportive care computer 'app' and telephone support from nursing, exercise and nutrition experts. In this way, the APOLLO team will learn the most helpful type and timing of supportive care from those who know best.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
eligible for allogeneic transplantation
Disqualifiers
none
Trial population
individuals scheduled to undergo allogeneic transplantation
Trial design
Cohort
Prospective
Treatments tested in this trial
Supportive nursing, nutritional and physical activity with a handheld 'app'
BehavioralSupportive nursing, nutritional and physical activity with a handheld 'app'
Treatment groups
Trial outcomes
Primary outcomes
Title: Acceptability of a multimodal supportive care
Description: Questionnaire to assess usefulness of a multimodal supportive care App that includes care navigation (nursing, exercise, nutrition)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.